One Potential Solution: A Bee Medicine

Editor's Note: This story is a supplement to the feature "Solving the Mystery of the Vanishing Bees."















Share on Tumblr

More In This Article

A Miami-based biotechnology start-up company called Beeologics is developing an antiviral drug that exploits an ancient immune mechanism called RNA interference. Cells in most animals and plants use short- interfering RNA (siRNA) segments to inhibit the formation of viral proteins; here siRNA designed to target IAPV would be fed to colonies as part of double-stranded RNA mixed into a syrup.



Comments

Add Comment
Leave this field empty

Add a Comment

You must sign in or register as a ScientificAmerican.com member to submit a comment.
Click one of the buttons below to register using an existing Social Account.

More from Scientific American

See what we're tweeting about

Scientific American Editors

More »

Free Newsletters


Get the best from Scientific American in your inbox

Solve Innovation Challenges

Powered By: Innocentive

  SA Digital
  SA Digital

Email this Article

One Potential Solution: A Bee Medicine

X
Scientific American Magazine

Subscribe Today

Save 66% off the cover price and get a free gift!

Learn More >>

X

Please Log In

Forgot: Password

X

Account Linking

Welcome, . Do you have an existing ScientificAmerican.com account?

Yes, please link my existing account with for quick, secure access.



Forgot Password?

No, I would like to create a new account with my profile information.

Create Account
X

Report Abuse

Are you sure?

X

Institutional Access

It has been identified that the institution you are trying to access this article from has institutional site license access to Scientific American on nature.com. To access this article in its entirety through site license access, click below.

Site license access
X

Error

X

Share this Article

X